Synthesis Theta
The recipe for efficiency by Universal Pack
The remote installation of a complete packaging line for 4-side-seal sachets has just ended. The pharmaceutical multinational company chose Universal Pack mainly for the high output in terms of cartons/minute, the possibility of compacting the sachets stack with ad hoc systems, the maximum flexibility in formats and reduced blueprint as opposed to competitors’ offer.
The Project
The collaboration between the multinational company and Universal Pack starts with a project concerning the making of a complete packaging line for producing 4-side-seal sachets and automatically inserting them in pre-glued cartons.
The need of the buyer was to adopt a technological solution that would allow maximum production flexibility, high output and compliance with pharmaceutical market requirements, in one solution.
Universal Pack’s answer has satisfied all the specific requests and is structured in the following areas:
The machine speed for 4-side-seal Theta: this vertical machine model allows to reach horizontal machines output, while reducing footprint to a large extent and keeping greater flexibility.
Another key factor in the choice is the compact footprint of the whole line proposed by Universal Pack compared to the equivalent offer by other market players.
The quality in terms of sachets endurance, product integrity and aesthetic beauty produced by Theta machine also affected the decision. The high quality is made possible by a new horizontal sealing concept and a specific liquid cooling system for the sealing parts, avoiding film and product stress during dosing.
Total flexibility in sachet and carton size: this is a key factor especially for contracting companies and companies managing several production batches.
Another reason not to underestimate is the possibility to compact the stacks of sachets before transferring them to the cartoning machine: this process allows to gain greater stability and insert more sachets with equal carton size.
In addition, complying with the goal of operations simplification, adjustments and formats change take place without the need for extra tools.
In order to guarantee the highest precision at any output, the packaging line was equipped with multilane checkweigher, thousandth load cells with direct feedback to the single lanes of the dosing unit. There is also a station for the manual reintegration of rejected sachets.
The extractable dosing system can be placed at ergonomic height to facilitate cleaning operations and format change.
To reduce operational costs while keeping maximum efficiency, it was agreed to provide a completely customized assistance and maintenance plan, including training, on site and remote assistance, predictive maintenance, 4.0.
Remote equipment installation.
10 Advantages of the Project:
• Output speed
• Compact blueprint
• Sachet quality
• Total flexibility in size
• Tool-free adjustments and format change
• Carton volume minimization
• Multilane checkweigher
• Extractable dosing unit
• Operational costs minimization
• Remote plant installation
Related News
-
News Novartis signs US$3.2 bn subcutaneous delivery deal with Alteogen
Swiss pharma giant secures access to Korean biotech's ALT-B4 hyaluronidase platform in milestone-heavy agreement, marking Alteogen's fourth major licensing deal of 2026 as competition intensifies in the subcutaneous drug delivery space.
-
News Women in Pharma: The philosophy of pharmaceutical leadership
In this latest instalment of our Women in Pharma series, we sit down with Clarissa Sowemimo-Coker, Chief Strategy Officer at Ambrose Healthcare and CPHI Middle East Advisory Board Member.
-
News The PSCI Supplier Partnership - Collaboration for Responsible Supply Chains
About the Pharmaceutical Supply Chain Initiative The Pharmaceutical Supply Chain Initiative (PSCI) is the leading, member-led association for pharmaceutical companies working collaboratively to build responsible supply chains. Founded in 2006 and es... -
News AstraZeneca shares plunge 8.9% after reports of BMS talks
Britain's largest drugmaker lost more than GBP£17 billion in market value following reports of preliminary merger discussions with Bristol Myers Squibb that could create a pharmaceutical giant worth nearly US$400 billion, though investors rem... -
News GSK announces £400 million investment in new Cambridge R&D centre
Pharmaceutical giant to establish flagship research facility on Cambridge Biomedical Campus as part of strategic pipeline acceleration
-
News The CPHI Sustainability Summit - Where Conversation Becomes Collaboration
The Report Was Never the Destination - “The future of pharmaceutical sustainability won’t be shaped by individual organisations working in isolation. It will be shaped by partnerships, shared expertise and the willingness to work diffe... -
News Trump's generic drug tariffs set to reshape global pharmaceutical supply chains
The US president has announced plans to impose tariffs of up to 200% on imported generic medicines from August 2028, giving manufacturers a two-year window to establish domestic production facilities. The move threatens to upend a global supply chain t... -
News Building Safer, More Responsible Pharmaceutical Supply Chains: PSCI Global Audit Insights
The Pharmaceutical Supply Chain Initiative (PSCI) has released its seventh annual Audit Findings Analysis Report, offering unprecedented insights into supplier practices across the global pharmaceutical and healthcare industry.With a record-breaking 24...